RD
Ryan Deschner Jefferies Latest Price Targets & Analyst Ratings
# | Stock | Price | Price Target |
Upside Downside | Rating | Date | |
---|---|---|---|---|---|---|---|
1 |
1
Liquidia Corp
LQDA
$2.48B
| $28.85 | $41 |
42%
upside
| Strong Buy | 25 days ago |
|
2 |
2
Trevi Therapeutics
TRVI
$854M
| $7.01 | $27 |
285%
upside
| Strong Buy | 1 month ago |
|
3 |
PVLA
3
Palvella Therapeutics, Inc. Common Stock
PVLA
$616M
| $55.68 | $54 |
3%
downside
| Outperform | 1 month ago |
|
4 |
4
Ardelyx
ARDX
$1.57B
| $6.52 | $12 |
84%
upside
| Outperform | 1 month ago |
|
5 |
5
Apellis Pharmaceuticals
APLS
$3.55B
| $28.13 | $50 |
78%
upside
| Outperform | 1 month ago |
|
6 |
6
Viking Therapeutics
VKTX
$3.03B
| $26.98 | $122 |
352%
upside
| Strong Buy | 1 month ago |
|
7 |
TVRD
7
Tvardi Therapeutics, Inc. Common Stock
TVRD
$292M
| $31.11 | $62 |
99%
upside
| Outperform | 1 month ago |
|
8 |
8
ARS Pharmaceuticals
SPRY
$995M
| $10.07 | $28 |
178%
upside
| Strong Buy | 7 months ago |
|